Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
Ozempic, although originally used to treat diabetes, is increasingly being prescribed off-label for weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Brakenridge SC, et al
LightRx has safe, non-invasive devices that use electromagnetic pulses, low level lasers, and radio frequencies that all work together to melt fat and reduce cellulite
Additionally, if patients experience symptoms of depression, addressing these with a healthcare provider is crucial
Ways to measure visceral fat include : DEXA scans The gold standard for measuring fat distribution, though mainly used in specialist clinics
